NAPLES, Fla. A Naples man said he and his family were discriminated against when a Southwest Airlines employee wouldn’t allow the same-sex couple, their three children and their grandmother to board as a family.
Grant Morse, his husband, Sam Ballachino, their three children and Ballachino’s mother were waiting in the family boarding area at the gate at the Buffalo, N.Y.,airport, ready to catch their flight to Fort Lauderdale on Saturday, when a gate agent quickly approached them.
“Excuse me, this is family boarding only,” Morse said the woman told them. “This is only for family boarding.”
Puzzled, Morse and Ballachino, both 54, looked at each other.
“Well, we are a family and we’re married, and these are our three kids,” Morse said they told the agent. “And that’s our 83-year-old mother that is helping us.”
best business to buy stock in: GRAVITY Co. Ltd.(GRVY)
- [By Max Byerly]
ILLEGAL ACTIVITY WARNING: “Gravity (GRVY) Receives Coverage Optimism Score of 0.17” was first published by Ticker Report and is the sole property of of Ticker Report. If you are viewing this story on another publication, it was copied illegally and reposted in violation of U.S. & international trademark and copyright laws. The legal version of this story can be viewed at https://www.tickerreport.com/banking-finance/3382037/gravity-grvy-receives-coverage-optimism-score-of-0-17.html.
- [By Cooper Creagan]
For example, if you had taken five minutes to set up a Night Trade on Gravity Co. (Nasdaq: GRVY) in October, you could’ve tripled your money, and then some.
best business to buy stock in: Avnet, Inc.(AVT)
- [By Stephan Byrd]
DekaBank Deutsche Girozentrale raised its stake in Avnet (NYSE:AVT) by 763.5% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 72,310 shares of the technology company’s stock after purchasing an additional 63,936 shares during the period. DekaBank Deutsche Girozentrale owned about 0.06% of Avnet worth $3,050,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
best business to buy stock in: Insys Therapeutics, Inc.(INSY)
- [By ]
Abbvie Inc. (ABBV) , for example, is generally just a pharmaceutical stock. However, the company also marketed Marinol, an FDA-approved synthetic cannabinoid meant to help nausea and vomiting in cancer and AIDS patients. INSYS Therapeutics, Inc. (INSY) is a pharmaceutical company that got approval from the U.S. Drug Enforcement Administration (DEA) for a synthetic cannabis – despite having donated to anti-marijuana advocacy groups in the past.
- [By Keith Speights]
In October 2017, I predicted that Insys Therapeutics (NASDAQ:INSY) could be the biggest comeback story of 2018.For a while, it looked like I was on the right track. Insys stock soared in the fourth quarter of 2017. By early January, it was one of the hottest marijuana stocks on the market. Then the momentum evaporated.
- [By Casey Wilson]
Others, like cannabis biotech firm Insys Therapeutics Inc. (Nasdaq: INSY), are direct plays in marijuana businesses that offer investors the opportunity for incredibly fast gains.
best business to buy stock in: Merrimack Pharmaceuticals, Inc.(MACK)
- [By Lisa Levin]
Check out these big penny stock gainers and losers
Aceto Corporation (NASDAQ: ACET) fell 41.9 percent to $4.30 in pre-market trading. ACETO board disclosed that it is taking proactive steps to address business and financial challenges. Canaccord Genuity downgraded Aceto from Buy to Sell.
Helios and Matheson Analytics Inc. (NASDAQ: HMNY) fell 25.3 percent to $2.86 in pre-market trading after reporting an ATM offering of $150 million.
Pier 1 Imports, Inc. (NYSE: PIR) fell 17.4 percent to $2.86 in pre-market trading after reporting a fourth quarter sales miss. Comps were down 7.5 percent in the quarter.
Sleep Number Corporation (NASDAQ: SNBR) fell 12.4 percent to $32.00 in pre-market trading following a first quarter earnings miss.
Paratek Pharmaceuticals, Inc. (NASDAQ: PRTK) fell 10.2 percent to $11.90 in pre-market trading on news of $125 million convertible debt offering.
Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK) shares fell 8 percent to $8.02 in pre-market trading after dropping 2.02 percent on Wednesday.
Exponent, Inc. (NASDAQ: EXPO) shares fell 5.6 percent to $80 in pre-market trading.
Lumentum Holdings Inc. (NASDAQ: LITE) shares fell 4.8 percent to $60.00 in pre-market trading after rising 1.78 percent on Wednesday.
vTv Therapeutics Inc. (NASDAQ: VTVT) fell 4.6 percent to $2.10 in pre-market trading after surging 84.87 percent on Wednesday.
Taiwan Semiconductor Manufacturing Company Limited (NYSE: TSM) shares fell 4.5 percent to $40.07 in pre-market trading after the company reported Q1 results.
Align Technology, Inc.. (NASDAQ: ALGN) fell 3.5 percent to $267.40 in pre-market trading after rising 1.61 percent on Wednesday.
Transocean Ltd. (NYSE: RIG) shares fell 3.5 percent to $12 in pre-market trading after the company issued quarterly fleet status report.
GoPro, Inc. (NASDAQ: GPRO) fell 3.2 percent to $4.90 in pre-market trading.
Unilever PLC (NYSE: UL) fell 2.6 percent to $54.73 in pre-market
- [By Shane Hupp]
Here are some of the media headlines that may have effected Accern Sentiment Analysis’s rankings:
Get Merrimack Pharmaceuticals alerts:
Edited Transcript of MACK earnings conference call or presentation 8-May-18 12:30pm GMT (finance.yahoo.com) Investors Purchase High Volume of Merrimack Pharmaceuticals Call Options (MACK) (americanbankingnews.com) Merrimack (MACK) Reports Wider-Than-Expected Loss in Q1 (finance.yahoo.com) Merrimack Pharmaceuticals (MACK) Announces Quarterly Earnings Results, Misses Expectations By $0.05 EPS (americanbankingnews.com) Merrimack Pharmaceuticals’ (MACK) CEO Richard Peters on Q1 2018 Results – Earnings Call Transcript (seekingalpha.com)
A number of equities analysts have issued reports on MACK shares. Robert W. Baird reiterated a “hold” rating and issued a $12.00 price objective on shares of Merrimack Pharmaceuticals in a report on Thursday, March 15th. Zacks Investment Research upgraded Merrimack Pharmaceuticals from a “hold” rating to a “buy” rating and set a $9.50 price objective for the company in a report on Wednesday, April 25th.
best business to buy stock in: Special Opportunities Fund Inc.(SPE)
- [By Max Byerly]
Spartan Energy (TSE:SPE) insider Albert Jason Stark sold 21,706 shares of Spartan Energy stock in a transaction dated Tuesday, May 8th. The stock was sold at an average price of C$6.48, for a total transaction of C$140,654.88.